Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NDAC

This article was originally published in The Tan Sheet

Executive Summary

Industry groups interested in selecting non-voting industry rep should submit letter to FDA by July 23, agency says in June 22 Federal Register notice. After 30 days, letters will be sent to all interested parties, who will be responsible for consulting with each other and selecting a single member within 60 days. Any nominations made by individuals or groups will be forwarded to organizations participating in selection process. Term of former NDAC industry liaison George Blewitt, MD, expired May 31

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel